4//SEC Filing
WENTWORTH TIMOTHY C 4
Accession 0001225208-21-004359
CIK 0001739940other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 8:27 PM ET
Size
19.4 KB
Accession
0001225208-21-004359
Insider Transaction Report
Form 4
WENTWORTH TIMOTHY C
Pres, Exp Scrpts & Cigna Svcs
Transactions
- Sale
Common Stock, $.01 Par Value
2021-03-01$214.07/sh−1,800$385,335→ 21,139 total(indirect: By Trust) - Tax Payment
Common Stock, $.01 Par Value
2021-02-26$209.90/sh−6,270$1,316,073→ 56,139 total - Sale
Common Stock, $.01 Par Value
2021-03-01$215.76/sh−400$86,306→ 23,339 total(indirect: By Trust) - Sale
Common Stock, $.01 Par Value
2021-03-01$215.26/sh−2,932$631,130→ 18,207 total(indirect: By Trust) - Tax Payment
Common Stock, $.01 Par Value
2021-02-26$210.31/sh−2,727$573,515→ 62,409 total - Tax Payment
Common Stock, $.01 Par Value
2021-02-26$210.31/sh−8,016$1,685,845→ 48,123 total - Sale
Common Stock, $.01 Par Value
2021-03-01$211.94/sh−200$42,388→ 23,739 total(indirect: By Trust) - Award
Common Stock, $.01 Par Value
2021-02-26+15,670→ 65,136 total - Sale
Common Stock, $.01 Par Value
2021-03-01$213.31/sh−400$85,325→ 22,939 total(indirect: By Trust)
Footnotes (10)
- [F1]The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2018-2020 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
- [F10]Represents the weighted average price of the shares sold. The prices actually received ranged from $214.73 to $215.72 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- [F2]Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
- [F3]Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units.
- [F4]Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.
- [F5]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 24, 2020.
- [F6]Represents the weighted average price of the shares sold. The prices actually received ranged from $211.58 to $212.30 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- [F7]Represents the weighted average price of the shares sold. The prices actually received ranged from $215.74 to $215.82 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- [F8]Represents the weighted average price of the shares sold. The prices actually received ranged from $212.64 to $213.58 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- [F9]Represents the weighted average price of the shares sold. The prices actually received ranged from $213.64 to $214.59 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
Documents
Issuer
Cigna Corp
CIK 0001739940
Entity typeother
Related Parties
1- filerCIK 0001252016
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 8:27 PM ET
- Size
- 19.4 KB